Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls
暂无分享,去创建一个
M. Thevis | H. Geyer | W. Schänzer | S. Beuck | G. Rodchenkov | I. Möller | A. Thomas | W. Bornatsch
暂无分享,去创建一个
M. Thevis | H. Geyer | W. Schänzer | S. Beuck | G. Rodchenkov | I. Möller | A. Thomas | W. Bornatsch